LEARN MORE
Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.
LEARN MOREPress Releases
Clinical Trials
Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.
Follow Us on Twitter
This article is PACKED with loads of accurate information, helpful advice, and what needs to change in order to... t.co/Z6Z307dOHJ
Retweeted by Marinus Pharma